Seelos Therapeutics Stock Alpha and Beta Analysis
| SEEL Stock | USD 0.34 0.01 3.03% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Seelos Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Seelos Therapeutics over a specified time horizon. Remember, high Seelos Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Seelos Therapeutics' market risk premium analysis include:
Beta 1.25 | Alpha (1.79) | Risk 8.28 | Sharpe Ratio (0.21) | Expected Return (1.73) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Seelos |
Seelos Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Seelos Therapeutics market risk premium is the additional return an investor will receive from holding Seelos Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Seelos Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Seelos Therapeutics' performance over market.| α | -1.79 | β | 1.25 |
Seelos Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Seelos Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Seelos Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Seelos Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Seelos Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Seelos Therapeutics shares will generate the highest return on investment. By understating and applying Seelos Therapeutics stock market price indicators, traders can identify Seelos Therapeutics position entry and exit signals to maximize returns.
Seelos Therapeutics Return and Market Media
The median price of Seelos Therapeutics for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 is 0.83 with a coefficient of variation of 33.94. The daily time series for the period is distributed with a sample standard deviation of 0.29, arithmetic mean of 0.85, and mean deviation of 0.25. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Seelos Therapeutics, Inc. Announces 4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules | 01/26/2024 |
2 | DHgate Partners with Seel to Offer On-time Delivery Guarantee | 02/22/2024 |
3 | Purchase by Smith Sandford D of 18200 shares of Seelos Therapeutics | 02/26/2024 |
4 | Is it Time to Dump Seelos Therapeutics Inc Stock After it Is Higher By 31.65 percent in a Week - InvestorsObserver | 02/27/2024 |
5 | Where Does Wall Street Think Seelos Therapeutics Inc Stock Will Go - InvestorsObserver | 03/06/2024 |
6 | Can Seelos Therapeutics Inc Stock Rise to the Top of Healthcare Sector Thursday - InvestorsObserver | 03/14/2024 |
7 | Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis Study with SLS-005 | 03/19/2024 |
8 | Seelos Therapeutics swings and misses on ALS drug study - Green Market Report | 03/20/2024 |
9 | Merrimack Pharmaceuticals and Seelos Therapeutics Critical Comparison - Defense World | 04/12/2024 |
About Seelos Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Seelos or other stocks. Alpha measures the amount that position in Seelos Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.003582 | 0.003761 | Price To Sales Ratio | 3.56 | 3.38 |
Seelos Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Seelos Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Seelos Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Seelos Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Seelos Therapeutics. Please utilize our Beneish M Score to check the likelihood of Seelos Therapeutics' management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Seelos Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Seelos Therapeutics Backtesting, Seelos Therapeutics Valuation, Seelos Therapeutics Correlation, Seelos Therapeutics Hype Analysis, Seelos Therapeutics Volatility, Seelos Therapeutics History and analyze Seelos Therapeutics Performance. For more information on how to buy Seelos Stock please use our How to buy in Seelos Stock guide.Note that the Seelos Therapeutics information on this page should be used as a complementary analysis to other Seelos Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Seelos Stock analysis
When running Seelos Therapeutics' price analysis, check to measure Seelos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seelos Therapeutics is operating at the current time. Most of Seelos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seelos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seelos Therapeutics' price. Additionally, you may evaluate how the addition of Seelos Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Seelos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.